BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9188859)

  • 1. B-Myb function can be markedly enhanced by cyclin A-dependent kinase and protein truncation.
    Lane S; Farlie P; Watson R
    Oncogene; 1997 May; 14(20):2445-53. PubMed ID: 9188859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator.
    Bessa M; Saville MK; Watson RJ
    Oncogene; 2001 Jun; 20(26):3376-86. PubMed ID: 11423988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-Myb repressor function is regulated by cyclin A phosphorylation and sequences within the C-terminal domain.
    Petrovas C; Jeay S; Lewis RE; Sonenshein GE
    Oncogene; 2003 Apr; 22(13):2011-20. PubMed ID: 12673206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-cycle regulation of B-Myb protein expression: specific phosphorylation during the S phase of the cell cycle.
    Robinson C; Light Y; Groves R; Mann D; Marias R; Watson R
    Oncogene; 1996 May; 12(9):1855-64. PubMed ID: 8649845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties.
    Saville MK; Watson RJ
    Oncogene; 1998 Nov; 17(21):2679-89. PubMed ID: 9840932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the cyclin D1 and cyclin A1 promoters by B-Myb is mediated by Sp1 binding sites.
    Bartusel T; Schubert S; Klempnauer KH
    Gene; 2005 May; 351():171-80. PubMed ID: 15922873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-Myb overcomes a p107-mediated cell proliferation block by interacting with an N-terminal domain of p107.
    Joaquin M; Bessa M; Saville MK; Watson RJ
    Oncogene; 2002 Nov; 21(52):7923-32. PubMed ID: 12439743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redundant functions of B-Myb and c-Myb in differentiating myeloid cells.
    Golay J; Broccoli V; Borleri GM; Erba E; Faretta M; Basilico L; Ying GG; Piccinini G; Shapiro LH; Lovrić J; Nawrath M; Mölling K; Rambaldi A; Introna M
    Cell Growth Differ; 1997 Dec; 8(12):1305-16. PubMed ID: 9419419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
    Morris L; Allen KE; La Thangue NB
    Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PARP co-activates B-MYB through enhanced phosphorylation at cyclin/cdk2 sites.
    Santilli G; Cervellera MN; Johnson TK; Lewis RE; Iacobelli S; Sala A
    Oncogene; 2001 Dec; 20(57):8167-74. PubMed ID: 11781832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of B-Myb activity by cyclin D1.
    Horstmann S; Ferrari S; Klempnauer KH
    Oncogene; 2000 Jan; 19(2):298-306. PubMed ID: 10645009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An alternatively spliced isoform of B-Myb is a transcriptional inhibitor.
    Horstmann S; Ferrari S; Klempnauer KH
    Oncogene; 2000 Nov; 19(48):5428-34. PubMed ID: 11114719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-Myb and cyclin D1 mediate heat shock element dependent activation of the human HSP70 promoter.
    Kamano H; Klempnauer KH
    Oncogene; 1997 Mar; 14(10):1223-9. PubMed ID: 9121772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linking Myb to the cell cycle: cyclin-dependent phosphorylation and regulation of A-Myb activity.
    Ziebold U; Klempnauer KH
    Oncogene; 1997 Aug; 15(9):1011-9. PubMed ID: 9285555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the cell cycle by B-Myb.
    Bessa M; Joaquin M; Tavner F; Saville MK; Watson RJ
    Blood Cells Mol Dis; 2001; 27(2):416-21. PubMed ID: 11259164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-regulation of B-Myb expression by E2F1 and EGF receptor.
    Hanada N; Lo HW; Day CP; Pan Y; Nakajima Y; Hung MC
    Mol Carcinog; 2006 Jan; 45(1):10-7. PubMed ID: 16299810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-MYB transactivates its own promoter through SP1-binding sites.
    Sala A; Saitta B; De Luca P; Cervellera MN; Casella I; Lewis RE; Watson R; Peschle C
    Oncogene; 1999 Feb; 18(6):1333-9. PubMed ID: 10022815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation and activation of B-Myb by cyclin A-Cdk2.
    Ziebold U; Bartsch O; Marais R; Ferrari S; Klempnauer KH
    Curr Biol; 1997 Apr; 7(4):253-60. PubMed ID: 9094315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases.
    Wang H; Shao N; Ding QM; Cui J; Reddy ES; Rao VN
    Oncogene; 1997 Jul; 15(2):143-57. PubMed ID: 9244350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1-dependent regulation of B-myb activity in early stages of neuroblastoma differentiation.
    Cesi V; Tanno B; Vitali R; Mancini C; Giuffrida ML; Calabretta B; Raschellà G
    Cell Death Differ; 2002 Nov; 9(11):1232-9. PubMed ID: 12404122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.